Switch to:
Also traded in: Germany
» Details

Insider Trades

Latest Guru Trades with ESMC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:OTCPK:BIAD, OTCPK:TMED, OTCBB:GTHP, OTCPK:VYCO, OTCPK:ECGI, AMEX:NSPR, OTCPK:PETV, OTCPK:AIRW, NAS:SSH, OTCPK:EQUR, NAS:MDGS, OTCPK:PBIO, OTCPK:ACARD, OTCPK:MPHMF, AMEX:XTNT, OTCPK:MRIC, NAS:DYNT, OTCPK:PYNGF, OTCPK:IGNG, NAS:PHMD » details
Traded in other countries:ES4.Germany,
Escalon Medical Corp operates in the healthcare market. The Company is engaged in the development, manufacture, marketing and distribution of medical devices for use in ophthalmology.

Escalon Medical Corp. ( 'Escalon') is a Pennsylvania corporation initially incorporated in California in 1987 and reincorporated in Pennsylvania in November 2001. The Company operates in the healthcare market specializing in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the areas of ophthalmology, diabetes, hematology and vascular access. Drew is a diagnostics Company specializing in the design, manufacture and distribution of instruments for blood cell counting and blood analysis. Drew is focused on providing instrumentation and consumables for the physician office and veterinary office laboratories. Drew sells two diabetic testing products: the DS5 and the Hb-Gold. The DS5 instrument, dispenser and associated reagent kit measure long-term glucose control in diabetic patients. Drew offers a array of equipment for use in the field of human and veterinary hematology. Sonomed develops, manufactures and markets ultrasound systems for diagnostic or biometric applications in ophthalmology. The systems are of four types: A-Scans, B-Scans, High Frequency B-Scans ( 'UBMs') and pachymeters. The A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. The B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. The UBM is a high frequency/high resolution ultrasound device, designed to provide highly detailed information of the anterior segment of the eye. The pachymeter uses the same principles as the A-Scan, but the system is tailored to measure the thickness of the cornea. The Company distributes two intraocular gas products C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery. The Company conducts development of medical devices for the diagnosis and monitoring of medical disorders in the areas of diabetes, cardiovascular diseases and hematology at the Company's Dallas, Texas, Miami, Florida and Rennes, France facilities. The Company conducts medical device and vascular access product development at its New Berlin, Wisconsin facility. The Company has 13 United States patents and 28 patents issued abroad that cover the Company's surgical products and pharmaceutical technology. The Company's competitors include ophthalmic-oriented companies that market a broad portfolio of products, including prescription ophthalmic pharmaceuticals, ophthalmic devices, consumer products and other eye care products; large integrated pharmaceutical companies that market a limited number of ophthalmic pharmaceuticals in addition to many other pharmaceuticals; and smaller specialty pharmaceutical and biotechnology companies. The Company's products are subject to stringent ongoing regulation by the FDA and similar health authoritie

Ratios

vs
industry
vs
history
P/B 0.73
ESMC's P/B is ranked higher than
94% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 3.17 vs. ESMC: 0.73 )
Ranked among companies with meaningful P/B only.
ESMC' s P/B Range Over the Past 10 Years
Min: 0.3  Med: 1.41 Max: 46.82
Current: 0.73
0.3
46.82
P/S 0.09
ESMC's P/S is ranked higher than
99% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 3.29 vs. ESMC: 0.09 )
Ranked among companies with meaningful P/S only.
ESMC' s P/S Range Over the Past 10 Years
Min: 0.06  Med: 0.59 Max: 1.4
Current: 0.09
0.06
1.4
Current Ratio 1.40
ESMC's Current Ratio is ranked lower than
80% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. ESMC: 1.40 )
Ranked among companies with meaningful Current Ratio only.
ESMC' s Current Ratio Range Over the Past 10 Years
Min: 0.51  Med: 2.42 Max: 6
Current: 1.4
0.51
6
Quick Ratio 0.72
ESMC's Quick Ratio is ranked lower than
87% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. ESMC: 0.72 )
Ranked among companies with meaningful Quick Ratio only.
ESMC' s Quick Ratio Range Over the Past 10 Years
Min: 0.27  Med: 1.37 Max: 5.29
Current: 0.72
0.27
5.29
Days Inventory 138.67
ESMC's Days Inventory is ranked lower than
53% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 130.88 vs. ESMC: 138.67 )
Ranked among companies with meaningful Days Inventory only.
ESMC' s Days Inventory Range Over the Past 10 Years
Min: 101.62  Med: 155.23 Max: 204.55
Current: 138.67
101.62
204.55
Days Sales Outstanding 48.35
ESMC's Days Sales Outstanding is ranked higher than
77% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 66.78 vs. ESMC: 48.35 )
Ranked among companies with meaningful Days Sales Outstanding only.
ESMC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.8  Med: 50.43 Max: 57.65
Current: 48.35
42.8
57.65
Days Payable 71.81
ESMC's Days Payable is ranked higher than
59% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 58.05 vs. ESMC: 71.81 )
Ranked among companies with meaningful Days Payable only.
ESMC' s Days Payable Range Over the Past 10 Years
Min: 32.18  Med: 46.66 Max: 86.2
Current: 71.81
32.18
86.2

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.10
ESMC's 3-Year Average Share Buyback Ratio is ranked higher than
82% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. ESMC: -0.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ESMC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -23.4  Med: -2.9 Max: 0
Current: -0.1
-23.4
0

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 2.33
ESMC's Price/Net Current Asset Value is ranked higher than
87% of the 234 Companies
in the Global Medical Devices industry.

( Industry Median: 6.59 vs. ESMC: 2.33 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ESMC' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.83  Med: 2.99 Max: 33.33
Current: 2.33
0.83
33.33
Price/Tangible Book 2.00
ESMC's Price/Tangible Book is ranked higher than
78% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 4.24 vs. ESMC: 2.00 )
Ranked among companies with meaningful Price/Tangible Book only.
ESMC' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.61  Med: 2.55 Max: 126.25
Current: 2
0.61
126.25
Price/Median PS Value 0.16
ESMC's Price/Median PS Value is ranked higher than
95% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 0.99 vs. ESMC: 0.16 )
Ranked among companies with meaningful Price/Median PS Value only.
ESMC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.13  Med: 1.15 Max: 10.57
Current: 0.16
0.13
10.57
Earnings Yield (Greenblatt) (%) -77.32
ESMC's Earnings Yield (Greenblatt) (%) is ranked lower than
90% of the 337 Companies
in the Global Medical Devices industry.

( Industry Median: -0.30 vs. ESMC: -77.32 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ESMC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -77.5  Med: 456.85 Max: 677.7
Current: -77.32
-77.5
677.7
Forward Rate of Return (Yacktman) (%) 145.37
ESMC's Forward Rate of Return (Yacktman) (%) is ranked higher than
99% of the 123 Companies
in the Global Medical Devices industry.

( Industry Median: 8.88 vs. ESMC: 145.37 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ESMC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -67.7  Med: -6.85 Max: 145.37
Current: 145.37
-67.7
145.37

More Statistics

Revenue (TTM) (Mil) $11.30
EPS (TTM) $ -0.14
Beta0.03
Short Percentage of Float0.03%
52-Week Range $0.07 - 1.29
Shares Outstanding (Mil)7.55
» More Articles for OTCPK:ESMC

Headlines

Articles On GuruFocus.com
Escalon Medical Corp. Reports Operating Results (10-Q) Nov 15 2010 
Escalon Medical Corp. Reports Operating Results (10-K) Oct 12 2010 
Escalon Medical Corp. Reports Operating Results (10-Q) May 20 2010 
Escalon Medical Corp. Reports Operating Results (10-Q) Nov 16 2009 
Escalon Medical Corp. Reports Operating Results (10-Q) May 15 2009 
Escalon Medical Corp. Reports Operating Results (10-Q) Feb 17 2009 

More From Other Websites
ESCALON MEDICAL CORP Financials Feb 18 2017
ESCALON MEDICAL CORP Files SEC form 10-Q, Quarterly Report Feb 14 2017
ESCALON MEDICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Jan 05 2017
Escalon Medical Corp. :ESMC-US: Earnings Analysis: Q1, 2017 By the Numbers : November 29, 2016 Nov 29 2016
ESCALON MEDICAL CORP Files SEC form 10-Q, Quarterly Report Nov 18 2016
ESCALON MEDICAL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Nov 16 2016
Escalon Medical Corp. :ESMC-US: Earnings Analysis: 2016 By the Numbers : October 20, 2016 Oct 20 2016
ESCALON MEDICAL CORP Files SEC form 10-K, Annual Report Oct 12 2016
ESCALON MEDICAL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Sep 06 2016
ESCALON MEDICAL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Aug 22 2016
Escalon Medical Corp. :ESMC-US: Earnings Analysis: Q3, 2016 By the Numbers May 19 2016
Escalon® Medical Corp. Reports Third Quarter Fiscal 2016 Results May 16 2016
ESCALON MEDICAL CORP Files SEC form 10-Q, Quarterly Report May 16 2016
ESCALON MEDICAL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Mar 07 2016
ESCALON MEDICAL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Feb 23 2016
/C O R R E C T I O N -- Escalon Medical Corp./ Feb 16 2016
ESCALON MEDICAL CORP Files SEC form 10-Q, Quarterly Report Feb 16 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK